glutathione s-transferase polymorphisms cancer incidence and therapy transferases: substrates, inihibitors pro-drugs in and neurodegenerative diseases Toxicogenomics of glutathione S-transferase (GST)

: Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs

Cornelis F

The best results are typically found by combining therapies

[19] [21] The compounds targeted in this manner by GSTs encompass a diverse range of environmental or otherwise exogenous toxins, including chemotherapeutic agents and other drugs, pesticides, herbicides, carcinogens, and variably-derived epoxides

Ichim T

A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting